1-3 of 3
Xiaojing Wang, PhD
Close
Sort by
Journal Articles

The Novel Aurora Kinase Inhibitor ENMD-2076 Has Potent Single Agent Activity against Multiple Myeloma (MM) in Vitro and in Vivo , and Shows Synergistic Activity in Combination with Lenalidomide

Xiaojing Wang, PhD, Anthony L. Sinn, Attaya Suvannasankha, MD, Colin D. Crean, Li Chen, MD, Shuhong Zhang, PhD, Jing Liang, MD, Genglin Zhang, Karen E. Pollok, PhD, Rafat Abonour, MD, Carolyn Sidor, MD, Mark R. Bray, PhD, Sherif S. Farag, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3660.
https://doi.org/10.1182/blood.V112.11.3660.3660
Published: 2008
Journal Articles

Synergistic Activity of Bendamustine in Combination with Doxorubicin and Bortezomib in Multiple Myeloma Cells

Shuhong Zhang, PhD, Xiaojing Wang, PhD, Li Chen, Jing Liang, Attaya Suvannasankha, MD, Rafat Abonour, MD, Sherif S Farag, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5171.
https://doi.org/10.1182/blood.V112.11.5171.5171
Published: 2008
Journal Articles

Unlike Inactivating PTEN Mutations, Pharmacological Inhibition of PTEN Does Not Increase the Sensitivity of Multiple Myeloma Cells to Inhibition of the PI3K/Akt/mTOR Pathway.

Xiaojing Wang, PhD, Shuhong Zhang, Ph.D, Xiaodong Peng, Ph.D, Joe Garlich, Ph.D, Li Chen, MD, Jing Liang, MD, Sherif Shafik Farag, MD, Ph.D
Journal: Blood
Blood (2007) 110 (11): 4785.
https://doi.org/10.1182/blood.V110.11.4785.4785
Published: 2007